Last update: Dec. 1, 2004


Low Risk for breastfeeding

Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.

It is a not sedative anti-histaminic drug without an anti-muscarinic activity. Avoid its use on patients affected of cardiac arrhythmia or along with erythromycin and/or ketoconazole o si el lactante está tomando un macrólido.


We do not have alternatives for Mizolastine.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.


Mizolastine belongs to this group or family:


Main tradenames from several countries containing Mizolastine in its composition:


Variable Value Unit
Oral Bioavail. 65 %
Molecular weight 433 daltons
Protein Binding 98 %
Tmax 1,5 hours
T1/2 13 hours


We are working to add the scientific references of this product. It will be available soon. If you wish to have access to this information, please let us know by leaving your comment in the opinion section below.

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at

e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) from Mexico

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM